XM does not provide services to residents of the United States of America.

Temenos names new CEO, says sales hit by Hindenburg report



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Temenos names new CEO, says sales hit by Hindenburg report</title></head><body>

Adds details on CEO change in paragraph 2, subscription deal revenue in paragraph 4, quotes from earnings call in paragraphs 5, 8-10

By Chiara Holzhaeuser and Louis van Boxel-Woolf

April 23 (Reuters) -Temenos TEMN.S reported first-quarter total software licensing revenue of $84 million on Tuesday, falling short of estimates, and announced the appointment of Jean-Pierre Brulard as chief executive.

Brulard, whose appointment will be effective May 1, will replace interim CEO Andreas Andreades, who was repeatedly put under pressure to step down by activist shareholder Petrus Advisers.

Total licensing revenue in the first quarter came inbelow theconsensus estimate of $100.2 million compiled by the Swiss banking software group, with subscription sales down 41% year-on-year.

Analysts had expected subscription deal revenue of $36.7 million for the quarter, but Temenos posted a figure of $20.1 million.

Temenos said in a statement that allegations of accounting irregularities madeby Hindenburg Research in a February report hadled to delays in client decision-making and a "temporary lengthening" of its sales cycles.

Hindenburg has a short position in Temenos and so stands to profit from a decline in itsshare price.

A special committee appointed by Temenos, which included outside accountants and lawyers, last week called Hindenburg's allegations "incorrect and misleading", sending the firm's sharesup 20% in a single day.

Chief Financial Officer Takis Spiliopoulos told analysts on an earnings call that he expects a "substantial" part of the subscriptions miss to be recovered in the second quarter "and maybe some in Q3".

The company's tendency to sign a smaller number of "big -ticket" deals meant the delay of "a few larger ones" has a substantial impact on revenue, Spiliopoulos said on the call.

Temenos confirmed its guidance for 2024.



Reporting by Chiara Holzhaeuser and Louis van Boxel-Woolf; Editing by Alison Williams, Alexander Smith and Leslie Adler

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.